tirzepatide dr mike is THAT GOOD - whether you lose weight or not.⁠ Full video is on the @RPSTRENGTH YouTube: Don’t Fall for MAHA Health Myths, Here’s What the Data Actually Says FDA approval for Zepbound (tirzepatide)

This combination approach has become a standard-of-care strategy in diabetes management guidelines

Introduced in 2021, these injections address obesity as a chronic metabolic condition, not just a problem of willpower or temporary lifestyle changes

Most clinical guidelines recommend this combination for type 2 diabetes patients not adequately controlled on metformin alone, particularly those with obesity

Usually, you start with 0.25 mg per week

However, a major shift occurred in November 2025 when the Trump administration negotiated MFN pricing deals with Novo Nordisk and Eli Lilly, reducing Medicare/Medicaid prices for Ozempic, Wegovy, Zepbound, and Mounjaro to approximately $245/month , with Medicare beneficiary co-pays of $50/month ( [17] ) ( [22] )